Scarica l'app Stockscreener
6.74
1.66%
0.11
Dopo l'orario di chiusura:
6.86
0.12
+1.78%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LFST Giù?
Forum
Previsione
Precedente Chiudi:
$6.63
Aprire:
$6.49
Volume 24 ore:
2.05M
Relative Volume:
1.34
Capitalizzazione di mercato:
$2.59B
Reddito:
$1.21B
Utile/perdita netta:
$-95.29M
Rapporto P/E:
-25.92
EPS:
-0.26
Flusso di cassa netto:
$35.06M
1 W Prestazione:
-0.44%
1M Prestazione:
-14.79%
6M Prestazione:
-1.75%
1 anno Prestazione:
+11.40%
Intervallo 1D:
$6.48
$6.78
Intervallo di 1 settimana:
$6.48
$6.81
Portata 52W:
$4.64
$8.61
Lifestance Health Group Inc Stock (LFST) Company Profile
Nome
Lifestance Health Group Inc
Settore
Industria
Telefono
602-767-2100
Indirizzo
4800 N. SCOTTSDALE ROAD, SCOTTSDALE
Confronta LFST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LFST
Lifestance Health Group Inc
|
6.74 | 2.59B | 1.21B | -95.29M | 35.06M | -0.26 |
|
HCA
Hca Healthcare Inc
|
349.14 | 85.96B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
25.66 | 15.06B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
132.86 | 12.98B | 20.97B | 3.13B | 2.39B | 31.21 |
|
DVA
Davita Inc
|
153.73 | 12.30B | 12.67B | 827.68M | 1.42B | 9.27 |
|
UHS
Universal Health Services Inc
|
188.73 | 12.27B | 15.42B | 1.03B | 956.84M | 15.02 |
Lifestance Health Group Inc Stock (LFST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-16 | Aggiornamento | Goldman | Neutral → Buy |
| 2024-01-03 | Iniziato | Barclays | Underweight |
| 2023-05-15 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-01-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-07 | Ripresa | Jefferies | Buy |
| 2022-03-17 | Downgrade | UBS | Buy → Neutral |
| 2021-11-09 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-08-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-06 | Iniziato | Goldman | Neutral |
| 2021-07-06 | Iniziato | JP Morgan | Overweight |
| 2021-07-06 | Iniziato | Jefferies | Buy |
| 2021-07-06 | Iniziato | Morgan Stanley | Overweight |
| 2021-07-06 | Iniziato | William Blair | Outperform |
Mostra tutto
Lifestance Health Group Inc Borsa (LFST) Ultime notizie
This Talkspace Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday - Benzinga
LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference - Quantisnow
LifeStance Health Group, Inc. (LFST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
April 2025's Leading Growth Companies With High Insider Ownership - simplywall.st
When Will LifeStance Health Group, Inc. (NASDAQ:LFST) Become Profitable? - Yahoo Finance
LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
LifeStance Health Group (NASDAQ:LFST) Is Carrying A Fair Bit Of Debt - simplywall.st
LifeStance Health EVP Lisa K. Miller sells $130,030 in stock By Investing.com - Investing.com Australia
Top Executive Sells Thousands of Lifestance Health Group Shares - TipRanks
LifeStance Health EVP Lisa K. Miller sells $130,030 in stock - Investing.com India
How to Take Advantage of moves in (LFST) - news.stocktradersdaily.com
A significant driver of top-line growth: LifeStance Health Group Inc (LFST) - SETE News
LifeStance Health Group’s chief digital officer sells $264,293 in stock By Investing.com - Investing.com Australia
Outpatient & Specialty Care Stocks Q4 Results: Benchmarking U.S. Physical Therapy (NYSE:USPH) - The Globe and Mail
LifeStance Health Group’s chief digital officer sells $264,293 in stock - Investing.com India
LifeStance Health Group Enters Oversold Territory (LFST) - Nasdaq
(LFST) Investment Analysis and Advice - Stock Traders Daily
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies LifeStance Health Group, Inc. (LFST) Investors of Class Action and to Actively Participate - ACCESS Newswire
LifeStance Health’s Earnings Call Highlights Strong Growth - TipRanks
March 2025 Growth Companies With Strong Insider Confidence - Simply Wall St
UBS Adjusts Price Target on Lifestance Health Group to $8.50 From $7.50, Maintains Neutral Rating - Marketscreener.com
LifeStance Health Group, Inc. (NASDAQ:LFST) Q4 2024 Earnings Call Transcript - MSN
LifeStance Health Group’s (LFST) Outperform Rating Reiterated at William Blair - Defense World
Analysts Set LifeStance Health Group, Inc. (NASDAQ:LFST) Target Price at $8.70 - Defense World
LifeStance Health Group (NASDAQ:LFST) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
LifeStance Health Group (NASDAQ:LFST) Posts Quarterly Earnings Results - MarketBeat
LifeStance Health Group (NASDAQ:LFST) Shares Gap Up Following Better-Than-Expected Earnings - MarketBeat
Is Now An Opportune Moment To Examine LifeStance Health Group, Inc. (NASDAQ:LFST)? - Yahoo Finance UK
LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Purchased by Blue Trust Inc. - Defense World
Critical Review: LifeStance Health Group (NASDAQ:LFST) and Vsee Health (NASDAQ:VSEE) - Defense World
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of LifeStance Health Group, Inc. (LFST) Investigation - ACCESS Newswire
LifeStance Health Group Reports Strong 2024 Growth - TipRanks
Earnings call transcript: LifeStance Health Q4 2024 beats EPS expectations By Investing.com - Investing.com South Africa
Dave Bourdon to join LifeStance Health as new CEO - MSN
LifeStance Health Group, Inc. SEC 10-K Report - TradingView
Lifestance Health Names Dave Bourdon as CEO, Ryan McGroarty as CFO -February 27, 2025 at 11:21 am EST - Marketscreener.com
Earnings call transcript: LifeStance Health Q4 2024 beats EPS expectations - Investing.com
Lifestance Health Group Inc reports results for the quarter ended December 31Earnings Summary - TradingView
LifeStance Health Group, Inc. Announces Chief Financial Officer Changes -February 27, 2025 at 06:02 am EST - Marketscreener.com
LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman - The Malaysian Reserve
Lifestance Health Group earnings beat by $0.03, revenue topped estimates - Investing.com UK
LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Lifestance Health Group's Q4 Loss Narrows, Revenue Rises; Provides 2025 Revenue Guidance - Marketscreener.com
Lifestance Health Group Announces Leadership Changes for 2025 - TipRanks
LifeStance Health Names Bourdon CEO; Burdick Becomes Executive Chairman - MarketWatch
LifeStance Health Group (NASDAQ:LFST) Beats Expectations in Strong Q4, Stock Soars - Yahoo Finance
LifeStance Reports Fourth Quarter and Full Year 2024 Results - The Manila Times
How LifeStance's Mental Health Bet Paid Off: 19% Revenue Surge and Doubled EBITDA - StockTitan
LifeStance Health Group (LFST) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
LifeStance Health Group (LFST) To Report Earnings Tomorrow: Here Is What To Expect By Stock Story - Investing.com Canada
LifeStance Health Group Insiders Sell US$6.3m Of Stock, Possibly Signalling Caution - Simply Wall St
Lifestance Health Group Inc Azioni (LFST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.01%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):